Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
European Journal of Medicinal Chemistry|March 18, 2014
Anti-mycobacterial activity of 1,3-diaryltriazenesDavie Cappoen, Jure Vajs, Cynthia Uythethofken, et al.Microbiology Spectrum|August 27, 2024
Characterization of novel double-reporter strains of <i>Mycobacterium abscessus</i> for drug discovery: a study in mScarletClara M Bento, Kevin van Calster, Tatiana Piller, et al.Journal of Microbiological Methods|June 8, 2017
Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepaciaBieke Vanhoutte, Davie Cappoen, Bidart de Macedo Maira, et al.Plos One|March 2, 2017
Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo modelsFreija Van den Driessche, Bieke Vanhoutte, Gilles Brackman, et al.European Journal of Medicinal Chemistry|December 21, 2011
Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agentsDavie Cappoen, Jan Jacobs, Tuyen Nguyen Van, et al.RSC Advances|September 15, 2022
Design, synthesis and biological evaluation of benzo-[<i>d</i>]-imidazo-[2,1-<i>b</i>]-thiazole and imidazo-[2,1-<i>b</i>]-thiazole carboxamide triazole derivatives as antimycobacterial agentsSurendar Chitti, Kevin Van Calster, Davie Cappoen, et al.European Journal of Medicinal Chemistry|November 29, 2020
Synthesis and structure-activity studies of novel anhydrohexitol-based Leucyl-tRNA synthetase inhibitorsDries De Ruysscher, Luping Pang, Stijn M G Lenders, et al.Chemistry & Biodiversity|January 4, 2023
Design, Synthesis, and Antimycobacterial Evaluation of Novel Tetrahydroisoquinoline Hydrazide AnalogsBoddupalli Venkata Siva Kumar, Yogesh Mahadu Khetmalis, Adinarayana Nandikolla, et al.RSC Advances|May 6, 2022
Correction: Seeking potent anti-tubercular agents: design and synthesis of substituted-<i>N</i>-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agentsSingireddi Srinivasarao, Adinarayana Nandikolla, Amaroju Suresh, et al.RSC Advances|May 2, 2022
Seeking potent anti-tubercular agents: design and synthesis of substituted-<i>N</i>-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agentsSingireddi Srinivasarao, Adinarayana Nandikolla, Amaroju Suresh, et al.Pageof 4